Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

MEDVi

Request full access

Telehealth platform for medically supervised weight loss.

Los Angeles, United StatesFounded 2024Biotech & Life Sciences

About MEDVi

MEDVi, LLC is a telehealth company specializing in physician-supervised weight management and metabolic health. The company was founded by Matthew Gallagher, who was later joined by his brother, Elliot. Leveraging AI tools, Matthew Gallagher launched the startup in two months with an initial investment of $20,000. In its first full year of business in 2025, MEDVi generated $401 million in sales with 250,000 customers. The company is on track to reach $1.8 billion in sales in 2026.

Headquartered in Newark, Delaware, MEDVi operates as a digital platform that connects patients with licensed U.S. healthcare providers for virtual consultations and treatment plans. The business model is a direct-to-consumer, cash-pay subscription service, meaning it does not accept insurance. Monthly membership fees cover medical consultations, prescription medications, shipping, and ongoing support. The platform is designed to provide a more accessible and affordable alternative to traditional clinic-based weight loss programs.

MEDVi's core offering is its online weight loss program, which provides access to GLP-1 (glucagon-like peptide-1) agonist medications, such as compounded semaglutide and tirzepatide. These medications, available in injectable or oral tablet form, work by regulating appetite and slowing digestion. After an online health evaluation, a licensed physician reviews the patient's information to determine if a GLP-1 prescription is appropriate. If approved, the compounded medications are prepared by certified U.S. compounding pharmacies and shipped directly to the patient. The program includes 24/7 messaging support and unlimited appointments with providers. Beyond medication, MEDVi also offers personal care coaching, nutrition support from registered dietitians, and a meal delivery service called MEDVi Meals, designed to complement the GLP-1 treatments.

Source: Dealroom company data

At a glance

Founded
2024
Headquarters
Los Angeles, United States
Sector
Biotech & Life Sciences
Outcome tier
Thoroughbred$100M+ revenue

MEDVi in the Los Angeles ecosystem

Live from Dealroom

The MEDVi office with the hot startups, most funded companies and investors around it. Hover or tap a pin.

Loading the map…

Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →

Investors

1 investor on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Seed1 investor entered at this stage

  • Matthew Gallagher
Team profiled 1 named & role-tagged
Founders Hidden — book a demo/100 quality score
Key operators 1 quality Hidden — book a demo/100
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Global footprint

Workforce and web traffic by country
Workforce by country
🇺🇸 United States · Los Angeles HQ
Book a demo for the full country breakdown

Market sentiment

Posts on X, past 7 days

An AI-synthesised read of the highest-engagement posts about MEDVi on X, ranked by likes and reposts, corporate channels excluded.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See MEDVi on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.